(Q48465787)

11 February 2018

title

Adding to the controversy: pitfalls in the diagnosis of testosterone deficiency syndromes with questionnaires and biochemistry (English)

1 reference

11 February 2018

1 reference

1 reference

Morales A

1

1 reference

11 February 2018

Spevack M

2

1 reference

11 February 2018

Emerson L

3

1 reference

11 February 2018

Kuzmarov I

4

1 reference

11 February 2018

Casey R

5

1 reference

11 February 2018

Black A

6

1 reference

11 February 2018

Tremblay R

7

1 reference

11 February 2018

publication date

1 June 2007

1 reference

11 February 2018

published in

The Aging Male

1 reference

11 February 2018

volume

10

1 reference

11 February 2018

issue

2

1 reference

11 February 2018

page(s)

57-65

1 reference

11 February 2018

Dehydroepiandrosterone sulfate and aging

cites work

1 reference

https://api.crossref.org/works/10.1080%2F13685530701342686

The Aging Males' Symptoms scale (AMS) as outcome measure for treatment of androgen deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701342686

Multicenter study on the prevalence of sexual symptoms in male hypo- and hyperthyroid patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701342686

Can growth hormone prevent aging?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701342686

Evaluation of assays available to measure free testosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701342686

Interest of the androgen deficiency in aging males (ADAM) questionnaire for the identification of hypogonadism in elderly community-dwelling male volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701342686

Comparison of screening questionnaires for the diagnosis of hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701342686

Can we get away from serum total testosterone in the diagnosis of andropause?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701342686

The reliability of clinical and biochemical assessment in symptomatic late-onset hypogonadism: can a case be made for a 3-month therapeutic trial?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701342686

Dehydroepiandrosterone supplementation improves endothelial function and insulin sensitivity in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701342686

Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701342686

DHEA and peripheral androgen and estrogen formation: intracinology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701342686

Dehydroepiandrosterone modulates endothelial nitric oxide synthesis via direct genomic and nongenomic mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701342686

Effect of growth hormone (GH) and/or testosterone replacement on the prostate in GH-deficient adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701342686

10.1080/13685530701342686

21 January 2018

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018